Kensler et al. analyzed data from the Breast International Group Trial 1–98, and reported that AR expression was not associated with breast cancer-free interval (HR, 1.07; 95% CI, 0.83–1.36; p  =  0.60) [2]. This evidence concerns the gene AR and breast carcinoma.